BURLINGTON, Mass., Feb. 9 /PRNewswire-FirstCall/ -- Palomar Medical
Technologies Inc (Nasdaq: PMTI) announced the introduction of it's next
generation pulsed-light and laser system, the Palomar StarLux(TM), this past
weekend at the American Academy of Dermatology's (AAD) 62nd Annual Meeting in
Washington, DC. The StarLux includes all of the pulsed light handpieces
available on prior Palomar pulsed light systems plus the new Lux1064 YAG laser
handpiece to treat vascular lesions including leg veins.
The Palomar StarLux pulsed-light and laser system is computer controlled
for easy operation and provides physicians with an adjustable "smooth pulse"
energy output and integrated contact cooling at the sapphire tip for added
safety and patient comfort. Optimum spectrum selection plus higher power and
fast repetition rate have been incorporated into this ultra-compact pulsed
light design to rival the performance of much higher priced, single
application laser technology. Like the MediLux(TM), EsteLux(TM) and
NeoLux(TM) systems, the StarLux has many versatile handpieces that can be used
for the removal of hair, treatment of acne (pending FDA clearance) and for
photofacial applications for the treatment of pigmented and vascular lesions
to improve skin tone and texture. In addition, the StarLux has the new
Lux1064 YAG laser handpiece to treat vascular lesions including leg veins.
Chief Executive Officer Joseph P. Caruso commented, "Palomar came to this
year's AAD meeting feeling invigorated having just announced the Company's
outstanding financial results for the calendar year ended 2003 as well as
earlier in 2003 announcing a major strategic agreement with The Gillette
Company (NYSE: G) to complete development and commercialize a patented home-
use, light-based hair removal device for women. Along with this momentum, we
were able to announce at the AAD the next generation Lux system. Needless to
say, we believe 2004 will be a very exciting year for Palomar."
Caruso continued, "Palomar is proud of its continued improvement to the
Lux system platform. Palomar has kept its commitment to continually provide
value to customers who invest in our Lux system platform. The StarLux,
MediLux, EsteLux and NeoLux systems are the most affordable and versatile
cosmetic light-based systems on the market. The Lux platform enables us to
custom tailor our products to fit almost any professional medical office or
spa location. These systems offer a suite of applications at a fraction of
the cost of other competing systems."
Chief Financial Officer Paul S. Weiner commented, "We have recently
completed a very successful investor relation's roadshow at the AAD where we
met with managers of numerous investment funds and analysts to discuss
Palomar's strategic initiative and growth potential. The tremendous interest
generated in Palomar through these meetings is not surprising given the recent
financial results and successful implementation of our overall business
strategy. We look forward to continued positive meetings with investors and
fund managers in 2004."
About Palomar Medical Technologies Inc: Palomar is a leading researcher
and developer of light-based systems for hair removal and other cosmetic
treatments. In 2003, Palomar and The Gillette Company (NYSE: G) entered into
an agreement to complete development and commercialize a patented home-use,
light-based hair removal device for women. New and exciting indications are
being tested to further advance the hair removal market and other cosmetic
applications. Palomar pioneered the optical hair removal field, when, in
1996, it introduced the first high-powered laser hair removal system. Since
then, many of the major advances in light-based hair removal have been based
on Palomar technology. There are now millions of light-based hair removal
procedures performed around the world every year in physician offices,
clinics, spas and salons.
For more information on Palomar and its products, visit Palomar's website
at http://www.palomarmedical.com. To continue receiving the most up-to-date
information and latest news on Palomar as it happens, sign up to receive
automatic e-mail alerts by going to the E-mail Alerts page in the Investor
Relations section of the website.
With the exception of the historical information contained in this
release, the matters described herein contain forward-looking statements,
including but not limited to statements relating to new markets, development
and introduction of new products, and financial projections that involve risk
and uncertainties that may individually or mutually impact the matters herein,
and cause actual results, events and performance to differ materially from
such forward-looking statements. These risk factors include, but are not
limited to, results of future operations, technological difficulties in
developing or introducing new products, the results of future research, lack
of product demand and market acceptance for current and future products, the
effect of economic conditions, challenges in managing joint ventures and
research with third parties, the impact of competitive products and pricing,
governmental regulations with respect to medical devices, including whether
FDA clearance will be obtained for future products, the results of litigation,
difficulties in collecting royalties, potential infringement of third-party
intellectual property rights, and/or other factors, which are detailed from
time to time in the Company's SEC reports, including the report on Form 10-K
for the year ended December 31, 2002 and the Company's quarterly reports on
Form 10-Q. Readers are cautioned not to place undue reliance on these
forward-looking statements, which speak only as of the date hereof. The
Company undertakes no obligation to release publicly the result of any
revisions to these forward-looking statements that may be made to reflect
events or circumstances after the date hereof or to reflect the occurrence of
unanticipated events.
Contacts: Paul S. Weiner
Chief Financial Officer
Palomar Medical Technologies Inc
781-993-2411
ir@palomarmedical.com
SOURCE Palomar Medical Technologies Inc
 back to top
Related links:
http://www.palmed.com
Company News On-Call:
http://www.prnewswire.com/comp/107555.html
CONTACT:
Paul S. Weiner, Chief Financial Officer of
Palomar Medical Technologies Inc, +1-781-993-2411,
ir@palomarmedical.com
|
